VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 5, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (“ALDA”) announces that it has granted incentive stock options to a consultant to purchase an aggregate of 250,000 common shares at an exercise price of $0.80 and a term of three years, expiring on May 5, 2011. The options and shares issuable upon exercise, if any, will be subject to a four-month hold period from the date of grant in accordance with TSX Venture Exchange policy. The grant was pursuant to the Company’s Rolling Stock Option Plan, which was re-affirmed by the shareholders of the Company on December 14, 2007 and subsequently accepted by the Exchange. The total number of options outstanding after this grant will be 4,800,000.
